Abstract
GVHD is a common complication in patients after allo-SCT. Early detection is important because early therapy may improve the outcome. We evaluated contrast-enhanced ultrasound (CEUS) in patients with GVHD to assess typical imaging features. CEUS was performed in nine patients with histologically proven GVHD. As a control four healthy volunteers and six patients with Crohn's disease (CD) were examined. We employed a high-resolution multi-frequency transducer (6–9 MHz) with contrast harmonic imaging. After the injection of 2.4 mL SonoVue (Bracco, Milan, Italy) intravenously data were acquired and stored digitally. Regions of interest were manually placed over the surrounding mesenteric fat, bowel wall and bowel lumen. Maximum signal increase of each compartment was calculated. Patients with CD and GVHD showed significant contrast uptake in the bowel wall. In contrast to CD patients and healthy volunteers, patients with GVHD showed transmural penetration of microbubbles into the bowel lumen. We assume that the damaged gut mucosal barrier in GVHD enables the microbubbles to penetrate through the bowel wall into the bowel lumen. The penetration of microbubbles into the bowel lumen may serve as a novel diagnostic feature for GVHD if confirmed in controlled clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.
Washington K, Jagasia M . Pathology of graft-versus-host disease in the gastrointestinal tract. Human Pathol 2009; 40: 909–917.
Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77: 1821–1828.
Schreyer AG, Finkenzeller T, Gossmann H, Daneschnejad M, Muller-Wille R, Schacherer D et al. Microcirculation and perfusion with contrast-enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008; 40: 143–155.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Schneider M . SonoVue, a new ultrasound contrast agent. Eur Radiol 1999; 9 (Suppl 3): S347–S348.
Ma Q, Ma Y, Gong X, Zhang D . Improvement of tissue harmonic imaging using the pulse-inversion technique. Ultrasound Med Bio 2005; 31: 889–894.
Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361–370.
Brodoefel H, Bethge W, Vogel M, Fenchel M, Faul C, Wehrmann M et al. Early and late-onset acute GvHD following hematopoietic cell transplantation: CT features of gastrointestinal involvement with clinical and pathological correlation. Eur J Radiol 2010; 73: 594–600.
Schulenburg A, Turetschek K, Wrba F, Vogelsang H, Greinix HT, Keil F et al. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004; 83: 101–106.
Worawattanakul S, Semelka RC, Kelekis NL, Sallah AS . MR findings of intestinal graft-versus-host disease. Magn Reson Imaging 1996; 14: 1221–1223.
Mentzel HJ, Kentouche K, Kosmehl H, Gruhn B, Vogt S, Sauerbrey A et al. US and MRI of gastrointestinal graft-versus-host disease. Pediatr Radiol 2002; 32: 195–198.
Klein SA, Martin H, Schreiber-Dietrich D, Hermann S, Caspary WF, Hoelzer D et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001; 115: 929–934.
Gorg C, Wollenberg B, Beyer J, Stolte MS, Neubauer A . High-resolution ultrasonography in gastrointestinal graft-versus-host disease. Ann Hematol 2005; 84: 33–39.
Fegan C, Poynton CH, Whittaker JA . The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990; 5: 373–377.
Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D et al. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol 2010; 159: 87–92.
Melson J, Jakate S, Fung H, Arai S, Keshavarzian A . Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol 2007; 82: 881–886.
Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 2004; 103: 4681–4684.
Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA et al. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis. Transplantation 1995; 60: 949–957.
Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018–2024.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Schreyer, A., Landfried, K., Zorger, N. et al. Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplant 46, 1006–1011 (2011). https://doi.org/10.1038/bmt.2010.232
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.232
Keywords
This article is cited by
-
Acute graft-versus-host disease
Nature Reviews Disease Primers (2023)
-
PET assessment of acute gastrointestinal graft versus host disease
Bone Marrow Transplantation (2023)
-
Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound
Bone Marrow Transplantation (2019)
-
18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study
Bone Marrow Transplantation (2014)
-
Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography
Bone Marrow Transplantation (2013)